Assure Holdings Investor Presentation — May 2022

Document content

First Quarter 2022 Results

Cautionary Note regarding Forward -Looking Statements

This presentation may contain “forward -looking statements” within the meaning of applicable securities laws. Forward -looking sta tements may generally be identified by the use of the words "anticipates," "expects," "intends," "plans,"

"should," "could," "would," "may," "will," "believes," "estimates," "potential," "target," or "continue" and variations or si milar expressions. Forward -looking statements include, but are not limited to, statements regarding forecasts of managed

cases and remote neurology managed cases, the potential for accretive M&A work, potential margin improvement with scale in re mot e neurology services, lower costs of delivery and improved quality of services from remote neurology

services, potential for expansion into adjacent markets, targeted states for growth, and expansion opportunities. These state men ts are based upon the current expectations and beliefs of management and are subject to certain risks and

uncertainties that could cause actual results to differ materially from those described in the forward -looking statements. These risks include risks regarding our patient volume or cases not growing as expected, or decreasing, which could

impact revenue and profitability; unfavorable economic conditions could have an adverse effect on our business; risks related toincreased leverage resulting from incurring additional debt; the policies of health insurance carriers may affect the

amount of revenue we receive; our ability to successfully market and sell our products and services; we may be subject to com petition and technological risk which may impact the price and amount of services we can sell and the nature of

services we can provide; regulatory changes that are unfavorable in the states where our operations are conducted or concentr ated; our ability to comply and the cost of compliance with extensive existing regulation and any changes or

amendments thereto; changes within the medical industry and third -party reimbursement policies and our estimates of associated t iming and costs with the same; our ability to adequately forecast expansion and the Company’s management

of anticipated growth; and risks and uncertainties discussed in our most recent annual and quarterly reports filed with the U nited States Securities and Exchange Commission, including our annual report on Form 10 -K filed on March 14, 2022,

and with the Canadian securities regulators and available on the Company’s profiles on EDGAR at www.sec.gov and SEDAR at www.sedar.com , which risks and uncertainties are incorporated herein by reference. Readers are cautioned not to

place undue reliance on forward -looking statements. Except as required by law, Assure does not intend, and undertakes no obligat ion, to update any forward -looking statements to reflect, in particular, new information or future events.